You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1030 PSGL-1-deficiency suppresses tumor growth of orthotopic pancreatic ductal adenocarcinoma tumors and enhances immune cell infiltration and CD8+ T cell responses

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune Cell Types and Biology
1030 PSGL-1-deficiency suppresses tumor growth of orthotopic pancreatic ductal adenocarcinoma tumors and enhances immune cell infiltration and CD8+ T cell responses
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hope J, Zhang Y, Palete A, et al
1030 PSGL-1-deficiency suppresses tumor growth of orthotopic pancreatic ductal adenocarcinoma tumors and enhances immune cell infiltration and CD8+ T cell responses
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1030